Treatment of unexplained syncope: a multicenter, randomized trial of cardiac pacing guided by adenosine 5'-triphosphate testing

Flammang, Daniel;Church, Timothy R;De Roy, Lucas;Blanc, Jean-Jacques;ATP Multicenter Study.;et.al.
(2012) Circulation — Vol. 125, n° 1, p. 31-36 (2012)

Files

FlammangDetalCirculation2012.pdf
  • Restricted Access
  • Adobe PDF
  • 286.24 KB

Details

Authors
  • Flammang, Daniel
    Author
  • Church, Timothy R
    Author
  • De Roy, LucasUCLouvain
    Author
  • Blanc, Jean-Jacques
    Author
  • Purnode, PhilippeUCLouvain
    Author
  • ATP Multicenter Study.
    Author
Show more
Abstract
BACKGROUND: The origin of 40% of syncope cases remains unknown even after a complete diagnostic workup. Previous studies have suggested that ATP testing has value in selecting successful therapy. This patient-blinded, multicenter, randomized superiority trial tested whether, in patients with syncope of unknown origin, selecting cardiac pacing in those with a positive ATP test leads to fewer recurrences than those who do not receive pacing. METHODS AND RESULTS: From 2000 to 2005, 80 consenting patients (mean age, 75.9±7.7 years; 81% women; 56% without diagnosed structural heart disease) with syncope of unknown origin and atrioventricular or sinoatrial block lasting >10 seconds (average, 17.9±6.8 seconds) under ATP administration (20-mg IV bolus) were recruited from 10 hospitals, implanted with programmable pacemakers, and randomized to either active pacing (dual-chamber pacing at 70 bpm) or backup pacing (atrial pacing at 30 bpm). Patients were followed up regularly for up to 5 years for any syncope recurrence, the primary outcome. Mean follow-up was 16 months. Syncope recurred in 8 of 39 patients (21%) randomized to active pacing and in 27 of 41 (66%) randomized to backup pacing (control), yielding a hazard ratio of 0.25 (95% confidence interval, 0.12-0.56). After recurrence, the 27 recurrent control patients were reprogrammed to active pacing, and only 1 reported subsequent syncope. CONCLUSION: This study suggests that, in elderly patients with syncope of unknown origin and positive ATP tests, active dual-chamber pacing reduces syncope recurrence risk by 75% (95% confidence interval, 44-88). CLINICAL TRIAL REGISTRATION: URL: http://www.controlled-trials.com/ISRCTN00029383. Unique identifier: ISRCTN00029383.
Affiliations

Citations

Flammang, D., Church, T. R., De Roy, L., Blanc, J.-J., Leroy, J., Mairesse, G. H., Otmani, A., Graux, P. J., Frank, R., Purnode, P., & ATP Multicenter Study. (2012). Treatment of unexplained syncope: a multicenter, randomized trial of cardiac pacing guided by adenosine 5′-triphosphate testing. Circulation, 125(1), 31-36. https://doi.org/10.1161/CIRCULATIONAHA.111.022855 (Original work published 2012)